Our mission is to support research efforts to achieve the primary prevention
of breast and ovarian cancers. The focus of our efforts is to obtain
federal funding for a “Women’s Health Initiative” to facilitate
clinical trials for the primary immune prevention
of breast and ovarian cancer in otherwise healthy, cancer-free women.
Click on the picture above for a Downloadable brochure
-
About 1 in 8 U.S. women (about 12.4%) will develop invasive breast cancer over the course of her lifetime.
-
In 2018, an estimated 266,120 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 63,960 new cases of non-invasive (in situ) breast cancer.
-
For women in the U.S., breast cancer death rates are higher than those for any other cancer, besides lung cancer.
-
Besides skin cancer, breast cancer is the most commonly diagnosed cancer among American women. In 2017, it's estimated that about 30% of newly diagnosed cancers in women will be breast cancers.